-
Posted by
Two Blokes Apr 23 -
Filed in
Stock
-
5 views
SAN DIEGO, CA / ACCESS Newswire / April 23, 2025 / Robbins LLP reminds stockholders that a class action was filed on behalf of all persons who purchased or otherwise acquired Zenas BioPharma, Inc. (NASDAQ:ZBIO) securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Zenas BioPharma's September 2024 initial public offering.Zenas BioPharma purports to be a "clinical stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies for patients in need." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
